A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
MarketBeat on MSN2d
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsThe supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...
Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site.The ad also hit a nerve with the ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...
When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback